FoxO1 Regulates Tlr4 Inflammatory Pathway Signalling in Macrophages
Overview
Molecular Biology
Authors
Affiliations
The macrophage-mediated inflammatory response is a key etiologic component of obesity-related tissue inflammation and insulin resistance. The transcriptional factor FoxO1 is a key regulator of cell metabolism, cell cycle and cell death. Its activity is tightly regulated by the phosphoinositide-3-kinase-AKT (PI3K-Akt) pathway, which leads to phosphorylation, cytoplasmic retention and inactivation of FoxO1. Here, we show that FoxO1 promotes inflammation by enhancing Tlr4-mediated signalling in mature macrophages. By means of chromatin immunoprecipitation (ChIP) combined with massively parallel sequencing (ChIP-Seq), we show that FoxO1 binds to multiple enhancer-like elements within the Tlr4 gene itself, as well as to sites in a number of Tlr4 signalling pathway genes. While FoxO1 potentiates Tlr4 signalling, activation of the latter induces AKT and subsequently inactivates FoxO1, establishing a self-limiting mechanism of inflammation. Given the central role of macrophage Tlr4 in transducing extrinsic proinflammatory signals, the novel functions for FoxO1 in macrophages as a transcriptional regulator of the Tlr4 gene and its inflammatory pathway, highlights FoxO1 as a key molecular adaptor integrating inflammatory responses in the context of obesity and insulin resistance.
Metformin as a strategy against false positives in F-FDG PET/CT due to inflammation.
Feng Y, Xiang X, Weng Y, Xia B, Li H, Li Y Heliyon. 2024; 10(23):e40269.
PMID: 39687197 PMC: 11647850. DOI: 10.1016/j.heliyon.2024.e40269.
MicroRNAs as Epigenetic Regulators of Obesity.
Engin A, Engin A Adv Exp Med Biol. 2024; 1460:595-627.
PMID: 39287866 DOI: 10.1007/978-3-031-63657-8_20.
Xu J, Li Y, Yang X, Li H, Xiao X, You J Sci Rep. 2024; 14(1):20913.
PMID: 39245773 PMC: 11381534. DOI: 10.1038/s41598-024-71569-y.
The Foxo1-YAP-Notch1 axis reprograms STING-mediated innate immunity in NASH progression.
Xu D, Qu X, Yang T, Sheng M, Bian X, Zhan Y Exp Mol Med. 2024; 56(8):1843-1855.
PMID: 39122845 PMC: 11372114. DOI: 10.1038/s12276-024-01280-5.
Zaim S, Pebworth M, McGrath I, Okada L, Weiss M, Reading J Nat Commun. 2024; 15(1):6828.
PMID: 39122670 PMC: 11316085. DOI: 10.1038/s41467-024-50612-6.